Skip to main content
. Author manuscript; available in PMC: 2024 Mar 6.
Published in final edited form as: SLAS Discov. 2019 Sep 30;25(2):137–147. doi: 10.1177/2472555219877183

HT-CETSA (experimental details) Table:

Target Approach Cell Line Cell Density (x10^6 / mL) Cell Number (x10^5) Treatment dose Treatment duration (h) Heating duration (min) Well format Refs
B-Raf AlphaScreen A375 15 6.0 10 uM 1–2 3 384 15
PARP1 AlphaScreen MDA-MB-436 4 2.0 10 uM 1–2 3 384 15
TS AlphaScreen K562 10 1.0 50 uM 2 3 384 17
P38a AlphaScreen HL60 not reported 0.16 DR 30 3 384 16
P38a NaLTSA HeLa 0.20 0.20 10 uM 0.5–1 3 96 22
P38a Imaging A-431 adherent 0.02 50 uM 0.5 3 384 21
Chk1 Imaging HT29 U2OS adherent 10 DR 0.17 3 96 19
SYMD3 HTDR-CETSA β-gal EFC HeLa 0.40 0.05 DR 2 3 384 35
Ido1 HTDR-CETSA β-gal EFC HeLa 0.40 0.05 DR 2 3 384 35
IDH1 SplitLuc HEK293 1.0 0.15 DR 1 3.5 384 39
LDHA SplitLuc HEK293 1.0 0.05 DR 1 3.5 1536 39
ALDH1A1 SplitLuc HEK293 1.0 0.05 DR 1 3.5 1536 39
CDK9 SplitLuc HEK293 1.0 0.05 DR 1 3.5 1536 39